Literature DB >> 15937969

Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature.

E T Jaeggi1, L K Hornberger, J F Smallhorn, J-C Fouron.   

Abstract

OBJECTIVE: To review the pattern of presentation, management and outcome of fetal complete atrioventricular block (CAVB) associated with major structural congenital heart disease (CHD), when compared to isolated CAVB.
METHODS: Retrospective analysis of the medical records and echocardiograms of all CAVB cases, diagnosed prenatally at two tertiary care centers between the years 1990 and 2002.
RESULTS: Of a total of 59 consecutive fetal cases of CAVB, 24 (41%) had underlying major CHD, mainly left isomerism (n = 18) and congenitally corrected transposition of the great arteries (cc-TGA) (n = 3). When compared to isolated CAVB (n = 35), cases with CHD were detected earlier (21 +/- 6 vs. 26 +/- 6 weeks; P < 0.02) and-despite comparable heart rates-more often had fetal hydrops (38% vs. 9%; P < 0.02), while pregnancy continuation (66% vs. 94%; P < 0.02) or prenatal treatment (19% vs. 64%; P < 0.001) was less likely. Of 16 CHD cases with pregnancy continuation, beta-inotropic treatment of fetal bradycardia was attempted in three cases: all had left isomerism and died early postnatally. Livebirth and 1-year survival rates of CAVB with CHD were 56% and 19%, respectively, when compared to isolated CAVB with 88% and 75%, respectively (P < 0.0001). The four neonatal survivors (one left isomerism, three cc-TGA) had heart rates persistently > 60 bpm throughout gestation and 3/4 underwent a biventricular repair.
CONCLUSIONS: Fetal CAVB with CHD continues to be associated with a poor outcome, in particular in the presence of left isomerism and fetal heart rates < 60 bpm. Copyright (c) 2005 ISUOG.

Entities:  

Mesh:

Year:  2005        PMID: 15937969     DOI: 10.1002/uog.1919

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  20 in total

1.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Authors:  Peter M Izmirly; Amit Saxena; Mimi Y Kim; Dan Wang; Sara K Sahl; Carolina Llanos; Deborah Friedman; Jill P Buyon
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

Review 2.  Fetal cardiac arrhythmia detection and in utero therapy.

Authors:  Janette F Strasburger; Ronald T Wakai
Journal:  Nat Rev Cardiol       Date:  2010-05       Impact factor: 32.419

Review 3.  Rhythm abnormalities of the fetus.

Authors:  Lisa K Hornberger; David J Sahn
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

4.  Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardia.

Authors:  Maria C Escobar-Diaz; Wayne Tworetzky; Kevin Friedman; Terra Lafranchi; Francis Fynn-Thompson; Mark E Alexander; Douglas Y Mah
Journal:  Pediatr Cardiol       Date:  2014-02-09       Impact factor: 1.655

5.  Preferential transmission of genetic risk variants of candidate loci at 6p21 from asymptomatic grandparents to mothers of children with neonatal lupus.

Authors:  Amit Saxena; Erin McDonnell; Paula S Ramos; Satria Sajuthi; Miranda C Marion; Carl D Langefeld; Jill P Buyon; Robert M Clancy
Journal:  Arthritis Rheum       Date:  2012-03

6.  Impact of fetal echocardiography.

Authors:  John M Simpson
Journal:  Ann Pediatr Cardiol       Date:  2009-01

7.  Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia).

Authors:  Maria C Escobar-Diaz; Kevin Friedman; Yishay Salem; Gerald R Marx; Brian T Kalish; Terra Lafranchi; Rahul H Rathod; Sitaram Emani; Tal Geva; Wayne Tworetzky
Journal:  Am J Cardiol       Date:  2014-06-06       Impact factor: 2.778

Review 8.  Perinatal arrhythmias.

Authors:  Nicole Sekarski; Erik Jan Meijboom; Stefano Di Bernardo; Tatiana Boulos Ksontini; Yvan Mivelaz
Journal:  Eur J Pediatr       Date:  2014-04-17       Impact factor: 3.183

Review 9.  Prevention and treatment in utero of autoimmune-associated congenital heart block.

Authors:  Amit Saxena; Peter M Izmirly; Barbara Mendez; Jill P Buyon; Deborah M Friedman
Journal:  Cardiol Rev       Date:  2014 Nov-Dec       Impact factor: 2.644

Review 10.  Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.

Authors:  Peter M Izmirly; Jill P Buyon; Amit Saxena
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.